Literature DB >> 28731447

Chromatin-Bound Oxidized α-Synuclein Causes Strand Breaks in Neuronal Genomes in in vitro Models of Parkinson's Disease.

Velmarini Vasquez1,2,3, Joy Mitra1, Pavana M Hegde1, Arvind Pandey1, Shiladitya Sengupta1,4, Sankar Mitra1,4, K S Rao2, Muralidhar L Hegde1,5,4.   

Abstract

Alpha-synuclein (α-Syn) overexpression and misfolding/aggregation in degenerating dopaminergic neurons have long been implicated in Parkinson's disease (PD). The neurotoxicity of α-Syn is enhanced by iron (Fe) and other pro-oxidant metals, leading to generation of reactive oxygen species in PD brain. Although α-Syn is predominantly localized in presynaptic nerve terminals, a small fraction exists in neuronal nuclei. However, the functional and/or pathological role of nuclear α-Syn is unclear. Following up on our earlier report that α-Syn directly binds DNA in vitro, here we confirm the nuclear localization and chromatin association of α-Syn in neurons using proximity ligation and chromatin immunoprecipitation analysis. Moderate (∼2-fold) increase in α-Syn expression in neural lineage progenitor cells (NPC) derived from induced pluripotent human stem cells (iPSCs) or differentiated SHSY-5Y cells caused DNA strand breaks in the nuclear genome, which was further enhanced synergistically by Fe salts. Furthermore, α-Syn required nuclear localization for inducing genome damage as revealed by the effect of nucleus versus cytosol-specific mutants. Enhanced DNA damage by oxidized and misfolded/oligomeric α-Syn suggests that DNA nicking activity is mediated by the chemical nuclease activity of an oxidized peptide segment in the misfolded α-Syn. Consistent with this finding, a marked increase in Fe-dependent DNA breaks was observed in NPCs from a PD patient-derived iPSC line harboring triplication of the SNCA gene. Finally, α-Syn combined with Fe significantly promoted neuronal cell death. Together, these findings provide a novel molecular insight into the direct role of α-Syn in inducing neuronal genome damage, which could possibly contribute to neurodegeneration in PD.

Entities:  

Keywords:  Alpha-synuclein; Parkinson’s disease; iPSC-derived neural progenitor cells; iron; neurodegeneration

Mesh:

Substances:

Year:  2017        PMID: 28731447      PMCID: PMC6172953          DOI: 10.3233/JAD-170342

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  64 in total

1.  Nuclear localization of alpha-synuclein and its interaction with histones.

Authors:  John Goers; Amy B Manning-Bog; Alison L McCormack; Ian S Millett; Sebastian Doniach; Donato A Di Monte; Vladimir N Uversky; Anthony L Fink
Journal:  Biochemistry       Date:  2003-07-22       Impact factor: 3.162

2.  Increased 8-OHdG levels in the urine, serum, and substantia nigra of hemiparkinsonian rats.

Authors:  Takao Yasuhara; Koichi Hara; Kapil D Sethi; John C Morgan; Cesario V Borlongan
Journal:  Brain Res       Date:  2006-12-26       Impact factor: 3.252

3.  Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments.

Authors:  Nelson B Cole; Diane D Murphy; Jacob Lebowitz; Luca Di Noto; Rodney L Levine; Robert L Nussbaum
Journal:  J Biol Chem       Date:  2004-12-21       Impact factor: 5.157

4.  Structure and dynamics of micelle-bound human alpha-synuclein.

Authors:  Tobias S Ulmer; Ad Bax; Nelson B Cole; Robert L Nussbaum
Journal:  J Biol Chem       Date:  2004-12-22       Impact factor: 5.157

5.  Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation.

Authors:  L Narhi; S J Wood; S Steavenson; Y Jiang; G M Wu; D Anafi; S A Kaufman; F Martin; K Sitney; P Denis; J C Louis; J Wypych; A L Biere; M Citron
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

6.  In vivo demonstration that alpha-synuclein oligomers are toxic.

Authors:  Beate Winner; Roberto Jappelli; Samir K Maji; Paula A Desplats; Leah Boyer; Stefan Aigner; Claudia Hetzer; Thomas Loher; Marçal Vilar; Silvia Campioni; Christos Tzitzilonis; Alice Soragni; Sebastian Jessberger; Helena Mira; Antonella Consiglio; Emiley Pham; Eliezer Masliah; Fred H Gage; Roland Riek
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-15       Impact factor: 11.205

7.  Binding of alpha-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes.

Authors:  Yong Peng; Chengshan Wang; Howard H Xu; You-Nian Liu; Feimeng Zhou
Journal:  J Inorg Biochem       Date:  2009-11-18       Impact factor: 4.155

8.  Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.

Authors:  E C Hirsch; J P Brandel; P Galle; F Javoy-Agid; Y Agid
Journal:  J Neurochem       Date:  1991-02       Impact factor: 5.372

9.  Prereplicative repair of oxidized bases in the human genome is mediated by NEIL1 DNA glycosylase together with replication proteins.

Authors:  Muralidhar L Hegde; Pavana M Hegde; Larry J Bellot; Santi M Mandal; Tapas K Hazra; Guo-Min Li; Istvan Boldogh; Alan E Tomkinson; Sankar Mitra
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

10.  Berberine and Curcumin Target Survivin and STAT3 in Gastric Cancer Cells and Synergize Actions of Standard Chemotherapeutic 5-Fluorouracil.

Authors:  Arvind Pandey; Kanchan Vishnoi; Sutapa Mahata; Satyendra Chandra Tripathi; Sri Prakash Misra; Vatsala Misra; Ravi Mehrotra; Manisha Dwivedi; Alok C Bharti
Journal:  Nutr Cancer       Date:  2015-10-22       Impact factor: 2.900

View more
  25 in total

Review 1.  Genetic predispositions of Parkinson's disease revealed in patient-derived brain cells.

Authors:  Jenne Tran; Helena Anastacio; Cedric Bardy
Journal:  NPJ Parkinsons Dis       Date:  2020-04-24

2.  An Inducible Alpha-Synuclein Expressing Neuronal Cell Line Model for Parkinson's Disease1.

Authors:  Velmarini Vasquez; Joy Mitra; George Perry; K S Rao; Muralidhar L Hegde
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 3.  The Role of DNA Damage in Neural Plasticity in Physiology and Neurodegeneration.

Authors:  Anna Konopka; Julie D Atkin
Journal:  Front Cell Neurosci       Date:  2022-06-23       Impact factor: 6.147

4.  Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies.

Authors:  David J Koss; Daniel Erskine; Andrew Porter; Pawel Palmoski; Hariharan Menon; Olivia G J Todd; Marta Leite; Johannes Attems; Tiago F Outeiro
Journal:  Acta Neuropathol Commun       Date:  2022-07-06       Impact factor: 7.578

Review 5.  Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes.

Authors:  S L Sison; S C Vermilyea; M E Emborg; A D Ebert
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-04       Impact factor: 5.081

6.  Deficiency in classical nonhomologous end-joining-mediated repair of transcribed genes is linked to SCA3 pathogenesis.

Authors:  Anirban Chakraborty; Nisha Tapryal; Tatiana Venkova; Joy Mitra; Velmarini Vasquez; Altaf H Sarker; Sara Duarte-Silva; Weihan Huai; Tetsuo Ashizawa; Gourisankar Ghosh; Patricia Maciel; Partha S Sarkar; Muralidhar L Hegde; Xu Chen; Tapas K Hazra
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-23       Impact factor: 11.205

Review 7.  A multi-faceted genotoxic network of alpha-synuclein in the nucleus and mitochondria of dopaminergic neurons in Parkinson's disease: Emerging concepts and challenges.

Authors:  Velmarini Vasquez; Joy Mitra; Haibo Wang; Pavana M Hegde; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2019-12-18       Impact factor: 11.685

8.  Alteration of the Conformational Dynamics of a DNA Hairpin by α-Synuclein in the Presence of Aqueous Two-Phase Systems.

Authors:  Sanjib K Mukherjee; Jim-Marcel Knop; Simone Möbitz; Roland H A Winter
Journal:  Chemistry       Date:  2020-08-06       Impact factor: 5.236

Review 9.  DNA damage and regulation of protein homeostasis.

Authors:  Tanya T Paull
Journal:  DNA Repair (Amst)       Date:  2021-06-08

Review 10.  Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders.

Authors:  Nelson de Oliveira Manzanza; Lucia Sedlackova; Raj N Kalaria
Journal:  Front Aging Neurosci       Date:  2021-06-25       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.